Alternatives to Syneos Health
Syneos Health is a Biotechnology tool: a fully integrated biopharmaceutical solutions organization providing clinical development and commercialization services to life sciences companies. Here are the 60 closest alternatives, compared on pricing, features and what real users say.
The 20 closest Biotechnology companies to Syneos Health
- Website
Precision Medicine Group51HealthTechFranklin, United States$275.0MSpecialized services for pharmaceutical and life sciences clients across product development and commercialization.
- Website
IQVIA18HealthcareDurham, United StatesLeveraging AI and advanced analytics to drive innovation in healthcare and life sciences.
- Website
CellCentric60BiotechnologyCambridge, United Kingdom$375.0MA clinical-stage biotechnology company developing inobrodib as a first-in-class, oral p300/CBP inhibitor for the treatment of multiple myeloma.
- Website
SOLVE FSHD40BiotechnologyVancouver, Canada$9.2MVenture philanthropy organization accelerating treatments for facioscapulohumeral muscular dystrophy (FSHD).
- Website
Moderna77BiotechnologyCambridge, United States$4.5BModerna is a biotechnology company pioneering mRNA medicine, best known for its COVID-19 vaccine and a broad pipeline of mRNA-based therapeutics.
- Website
Coefficient Bio70BiotechnologySan Francisco, United States$15.8BAI safety and research company building reliable, interpretable, and steerable AI systems.
- Website
BioNTech66BiotechnologyMainz, Germany$975.0MGlobal biopharmaceutical company pioneering mRNA-based immunotherapies and vaccines for cancer and infectious diseases.
- JUJuno Therapeutics66BiotechnologySeattle, United States$316.7M
Biotechnology company focused on developing cancer immunotherapies.
- Website
Kite Pharma66BiotechnologySanta Monica, United States$421.2MBiotechnology company developing and commercializing cell therapies for cancer treatment.
- Website
CRISPR Therapeutics64BiotechnologyZug, Switzerland$547.0MBiotechnology company developing transformative gene-based medicines using CRISPR/Cas9 gene editing technology.
- Website
Mammoth Biosciences63BiotechnologyBrisbane, United States$460.0MBiotechnology company leveraging ultracompact CRISPR systems for gene editing therapies and diagnostics.
- Website OROryon Cell Therapies62BiotechnologyBelmont, USA$21.0M
Clinical-stage biotechnology company developing autologous neuron replacement medicines for neurodegenerative disorders.
- Website
Epicrispr Biotechnologies62BiotechnologySouth San Francisco, United States$90.0MEpicrispr Biotechnologies is a biotechnology company developing novel epigenetic therapies, with a lead program targeting Facioscapulohumeral Muscular Dystrophy (FSHD).
- Website
Degron Therapeutics62BiotechnologySan Diego, USA$40.0MClinical-stage biotechnology company advancing molecular glue degrader (MGD) medicines.
- Website
Seaport Therapeutics62BiotechnologyCambridge, USA$340.0MDeveloping novel therapeutics to restore gut lymphatic function.
- Website
Vizgen61BiotechnologyWaltham, United States$169.5MSpatial multiomics company developing technologies for single-cell gene expression profiling in intact tissues.
- Website
Abcam61BiotechnologyCambridge, United Kingdom$256.9MGlobal supplier of life science research tools, including antibodies, reagents, and assays.
- Website
Infinimmune60BiotechnologyAlameda, United States$75.0MDeveloping human-derived antibodies for inflammatory diseases and cancer using AI and proprietary platforms.
- Website
Supernus Pharmaceuticals60BiotechnologyRockville, United States$17.5MBiopharmaceutical company developing and commercializing CNS disease treatments.
- Website
LifeMine Therapeutics Inc.60BiotechnologyWatertown, United States$543.0MClinical-stage biopharmaceutical company leveraging a proprietary platform to discover and develop novel precision medicines from fungi.
Showing the 20 closest matches. See the rest on the Syneos Health profile.
Compare Syneos Health head to head
Side by side on what each one does, what it costs, and what real users report.